A detailed history of Ayrton Capital LLC transactions in Pa Vmed Inc. stock. As of the latest transaction made, Ayrton Capital LLC holds 2,244,235 shares of PAVM stock, worth $1.44 Million. This represents 25.49% of its overall portfolio holdings.

Number of Shares
2,244,235
Previous 449,600 399.16%
Holding current value
$1.44 Million
Previous $184,000 265.76%
% of portfolio
25.49%
Previous 6.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.22 - $0.5 $394,819 - $897,317
1,794,635 Added 399.16%
2,244,235 $673,000
Q2 2023

Aug 14, 2023

BUY
$0.35 - $0.56 $6,749 - $10,798
19,283 Added 4.48%
449,600 $184,000
Q1 2023

May 12, 2023

BUY
$0.36 - $0.63 $154,914 - $271,099
430,317 New
430,317 $159,000
Q3 2022

Nov 09, 2022

BUY
$0.57 - $34.65 $911,977 - $55.4 Million
1,599,961 New
1,599,961 $1.38 Million

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $58.2M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Ayrton Capital LLC Portfolio

Follow Ayrton Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ayrton Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ayrton Capital LLC with notifications on news.